Wednesday - September 2, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to NuScience Peptides
September 02, 2026
WASHINGTON, Sept. 2 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to NuScience Peptides LLC from its Center for Drug Evaluation and Research:

* * *

Recipient: Joseph and Ratsamy DeRosa, Managers, NuScience Peptides LLC, 20311 Chartwell Center Dr., Suite 212, Cornelius, NC 28031, United States, info@nusciencepeptides.com

Issuing Office: Center for Drug Evaluation and Research (CDER), Unit . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products